| # | Company | Location | Employees | Total Funding | Last Round | Last Funded |
|---|---|---|---|---|---|---|
| 1 |
OpenEvidence
OpenEvidence is a medical AI company that builds a search engine to support clin…
|
Cambridge | 11 - 50 | $767.0M | Series D | 2026-01-21 |
| 2 |
Medable
Medable is transforming clinical research and predictive medicine by creating a …
|
Palo Alto | 501 - 1K | $506.6M | Series D | 2021-10-26 |
| 3 |
Proxima
Proxima Bio develops programmable medicines that modulate protein interactions t…
|
New York | 11 - 50 | $86.3M | Seed | 2026-01-13 |
| 4 |
Canton Strategic Holdings
Canton Strategic Holdings drives institutional blockchain adoption via the Canto…
|
Chester | 11 - 50 | $618.5M | Post Ipo Equity | 2026-01-20 |
| 5 |
Lindus Health
Lindus Health is an anti-contract research organization that conducts end-to-end…
|
London | 101 - 250 | $79.5M | Grant | 2025-04-03 |
| 6 |
Spiro Medical
Spiro Medical is a medical device company developing a groundbreaking Pulmonary …
|
Menlo Park | 11 - 50 | $67.0M | Series A | 2026-01-07 |
| 7 |
PhaseV
PhaseV provides AI-driven solutions for efficient clinical development and opera…
|
Boston | 11 - 50 | $65.0M | Series A | 2025-05-13 |
| 8 |
Atropos Health
Atropos Health develops a clinical analytics platform that specializes in eviden…
|
New York | 11 - 50 | $47.0M | Series B | 2024-05-23 |
| 9 |
Sanguine
Bridging the gap between patients and researchers
|
Woburn | 101 - 250 | $12.2M | Debt Financing | 2023-10-31 |
| 10 |
Indivi
Indivi develops functional biomarkers that measure key disability concepts of im…
|
Basel | 51 - 100 | $23.0M | Series Unknown | 2025-11-12 |
| 11 |
Waiv
Owkin is an AI precision medicine company with a vision to find the right drug f…
|
New York | 251 - 500 | $337.1M | Series Unknown | 2026-03-12 |
| 12 |
Triomics
Triomics is a generative AI-powered platform that matches patients to clinical t…
|
San Francisco | 101 - 250 | $15.1M | Non Equity Assistance | 2024-07-02 |
| 13 |
Find therapeutics
Find therapeutics is operator of a drug discovery and development company intend…
|
Quebec | 1 - 10 | $15.3M | Series A | 2026-01-09 |
| 14 |
Circle Pharma
Circle Pharma is a biotechnology company creating bioavailable macrocyclic pepti…
|
San Francisco | 11 - 50 | $207.5M | Series D | 2024-09-03 |
| 15 |
Ryght AI
Ryght AI develops an enterprise-scale generative AI platform and applications to…
|
Laguna Beach | 11 - 50 | $5.5M | Seed | 2025-11-12 |
| 16 |
Dynavax Technologies
Dynavax Technologies is a biopharmaceutical company discovering and developing n…
|
Berkeley | 251 - 500 | $1.6B | Post Ipo Debt | 2025-03-06 |
| 17 |
NewLimit
NewLimit is a biotech company developing epigenetic therapies to extend human he…
|
South San Francisco | 11 - 50 | $247.2M | Convertible Note | 2025-10-20 |
| 18 |
Sky Labs
Skylabs is developing a healthcare wearable ring as part of its mission to devel…
|
Seongnam | 1 - 10 | $42.0M | Series Unknown | 2025-03-07 |
| 19 |
Unlearn.AI
Unlearn.AI combines AI, digital twins, and novel statistical methods to enable s…
|
San Francisco | 51 - 100 | $134.8M | Series C | 2024-02-08 |
| 20 |
SAB Biotherapeutics
SAB Biotherapeutics is a clinical-stage biopharmaceutical development company.
|
Sioux Falls | 51 - 100 | $446.3M | Post Ipo Equity | 2026-03-17 |
| 21 |
Dyania Health
Dyania Health’s medically specialized Synapsis AI automates manual chart review,…
|
Jersey City | 11 - 50 | $17.3M | Series A | 2024-10-24 |
| 22 |
Science 37
Science 37 is a clinical research company that facilitates universal participati…
|
Culver City | 501 - 1K | $347.5M | Post Ipo Equity | 2021-10-07 |
| 23 |
EpilepsyGTx
EpilepsyGTx is a late-stage biotech company exploring cutting-edge gene therapie…
|
Canterbury | 1 - 10 | $43.0M | Series A | 2025-12-10 |
| 24 |
Elucidata
Elucidata delivers ML-ready biomedical molecular data that is curated to acceler…
|
Cambridge | 101 - 250 | $23.6M | Series A | 2022-09-27 |
| 25 |
Baxter International
Baxter International through its subsidiaries, develops, manufactures and market…
|
Deerfield | c 10001 max | $2.3B | Post Ipo Debt | 2025-12-08 |
| 26 |
Broad Institute
The Broad Institute brings together a diverse group of individuals from across i…
|
Cambridge | 1K - 5K | $283.2M | Grant | 2025-11-18 |
| 27 |
Quibim
Quibim is a radiomics company specializing in quantitative imaging of biomarkers…
|
Valencia | 51 - 100 | $69.6M | Series A | 2025-01-28 |
| 28 |
TruDiagnostic
TruDiagnostic is a biodata research company that offers epigenetic testing and r…
|
Lexington | 51 - 100 | $321K | Grant | 2025-09-19 |
| 29 |
Draig Therapeutics
Draig Therapeutics is a clinical-stage biopharmaceutical startup.
|
Cardiff | 11 - 50 | $140.0M | Series A | 2025-06-18 |
| 30 |
Datavant
Datavant protects, connects, and delivers the world’s health data to power bette…
|
Phoenix | 5K - 10K | $80.5M | Series B | 2020-10-08 |
| 31 |
XRlabs
Where Surgical Intelligence Meets Extended Reality
|
London | 1 - 10 | $2.3M | Pre Seed | 2025-02-10 |
| 32 |
Cereno Scientific
Cereno Scientific develops therapies for cardiovascular diseases using epigeneti…
|
M├╢lndal | 11 - 50 | $86.9M | Post Ipo Equity | 2025-11-28 |
| 33 |
Cofactor Genomics
Cofactor Genomics builds multidimensional models of disease to deliver true prec…
|
San Francisco | 11 - 50 | $29.0M | Series Unknown | 2025-12-15 |
| 34 |
Character Biosciences
Character Biosciences is a platform that merges genomics with clinical data and …
|
Jersey City | 11 - 50 | $137.0M | Series B | 2025-09-17 |
| 35 |
argenx
argenx is a global immunology company committed to improving the lives of people…
|
Boston | 1K - 5K | $3.8B | Post Ipo Equity | 2023-07-18 |
| 36 |
Perceptive
Perceptive provides clinical research services including medical imaging, eClini…
|
London | 1K - 5K | $15.0M | Private Equity | 2026-01-08 |
| 37 |
Ultrahuman
Ultrahuman is a wearable tech start up that offers products that tracks metaboli…
|
Bangalore | 11 - 50 | $115.3M | Series C | 2026-02-27 |
| 38 |
UpTrials
UpTrials is an AI enabled staffing & operations platform for clinical trial team…
|
Chicago | 1 - 10 | $785K | Pre Seed | 2025-04-30 |
| 39 |
Pepgen
PepGen is empowering nucleic acid therapeutics to go the distance.
|
Oxford | 51 - 100 | $354.7M | Post Ipo Equity | 2025-09-24 |
| 40 |
Sapient
Biomarker discovery organization accelerating drug development through rapid, la…
|
San Diego | 51 - 100 | $13.8M | Grant | 2022-07-11 |
| 41 |
Tourmaline Bio
Tourmaline Bio is a biotechnology company that develops medicines to treat infla…
|
New York | 51 - 100 | $359.5M | Post Ipo Equity | 2024-01-25 |
| 42 |
AdvanCell
AdvanCell is a clinical-stage radiopharmaceutical company developing targeted al…
|
Sydney | 11 - 50 | $137.9M | Grant | 2025-04-13 |
| 43 |
Octave
Octave is a precision care company that provides diagnostic tools and care solut…
|
Menlo Park | 101 - 250 | $142.1M | Grant | 2025-10-06 |
| 44 |
myTomorrows
myTomorrows is a global platform that connects patients with unmet medical needs…
|
Amsterdam | 101 - 250 | $51.1M | Private Equity | 2025-11-11 |
| 45 |
Lykos Therapeutics
Lykos Therapeutics catalyzes healing and well-being through psychedelic drug dev…
|
San Jose | 101 - 250 | $150.0M | Series B | 2025-05-30 |
| 46 |
Leal Health
Leal is the leading AI-powered treatment decision support platform that democrat…
|
New York | 51 - 100 | $27.7M | Series A | 2022-02-07 |
| 47 |
Apriori Bio
Apriori Bio offers a platform for creating variant-resilient vaccines and provid…
|
Boston | 11 - 50 | $51.1M | Grant | 2024-07-08 |
| 48 |
Clinical Ink
Clinical Ink develops electronic documents recording software for recording sour…
|
Winston Salem | 51 - 100 | $35.0M | Series Unknown | 2020-12-03 |
| 49 |
TriNetX
TriNetX is a health research network that connects drug discovery and developmen…
|
Cambridge | 251 - 500 | $242.5M | Corporate Round | 2026-04-02 |
| 50 |
QuantHealth
Quant Health offers drug simulation, computational biology, clinical data scienc…
|
Tel Aviv | 11 - 50 | $17.0M | Series Unknown | 2025-10-01 |